1,720,963 research outputs found
Information brief for partners (November 2022): The Geneva Learning Foundation
No full text<p>This is a two-page introduction to the Geneva Learning Foundation for partners. For a more detailed introduction, <a href="https://doi.org/10.5281/zenodo.7057015">download our brochure</a>.</p>
<p><strong>The Geneva Learning Foundation</strong> (TGLF) (<a href="https://www.linkedin.com/company/geneva-learning-foundation/">LinkedIn</a> | <a href="http://youtube.com/c/TheGenevaLearningFoundation?sub_confirmation=1">YouTube</a> | <a href="https://www.learning.foundation/podcast">Podcast</a> | <a href="https://twitter.com/intent/follow?screen_name=DigitalScholarX">Twitter</a>) catalyzes large scale peer networks of frontline actors facing critical threats to our societies. </p>
<p>TGLF’s unique approach, rooted in decades of research and experience in <strong>learning science</strong>, uses the spark of <strong>intrinsic motivation</strong> to inspire individuals to link up and lead change. </p>
<p>TGLF develops and implements learning experiences that <strong>reach people in 137 countries</strong>. Our programmes <strong>scale</strong> quickly to connect thousands of learners and leaders working on the <strong>frontlines</strong> of conflicts, poverty, and other inequalities. We catalyze local expertise into innovation, action, and <strong>results</strong>.</p>
<p>The <strong>insights</strong> generated by and with learners are gathered, analyzed, and shared, for the benefit of communities and partners to scale and develop truly ground-tested and evidence-based policies and programmes.</p>
Introduction to the Geneva Learning Foundation
No full textThis brochure provides a detailed overview of the work of The Geneva Learning Foundation. Looking for a shorter introduction? Download our two-pager for partners…
The Geneva Learning Foundation (TGLF) (LinkedIn | YouTube | Podcast | Twitter) catalyzes large scale peer networks of frontline actors facing critical threats to our societies.
TGLF’s unique approach, rooted in decades of research and experience in learning science, uses the spark of intrinsic motivation to inspire individuals to link up and lead change.
TGLF develops and implements learning experiences that reach people in 137 countries. Our programmes scale quickly to connect thousands of learners and leaders working on the frontlines of conflicts, poverty, and other inequalities. We catalyze local expertise into innovation, action, and results.
The insights generated by and with learners are gathered, analyzed, and shared, for the benefit of communities and partners to scale and develop truly ground-tested and evidence-based policies and programmes
Value creation stories anonymized open data set (Immunization Agenda 2030 Full Learning Cycle, 7 March - 20 June 2022)
No full text<p># Title<br>
Immunization Agenda 2030 (IA2030) 1st Movement Full Learning Cycle (FLC 2022) – “How are you doing?” Value Creation Stories Survey (Version 1.0)</p>
<p># Research audience<br>
Education researchers interested in the application of the “value creation stories” (VCS) conceptual framework elaborated by Etienne Wenger et al. in the study of communities of practice and other types of digital communities.</p>
<p># Credits</p>
<p>## Author<br>
The Geneva Learning Foundation<br>
18 avenue Louis Casaï<br>
CH-1209 Geneva, Switzerland<br>
[email protected]</p>
<p>### Principal Investigator and corresponding author<br>
Reda Sadki, The Geneva Learning Foundation (TGLF)<br>
[email protected]</p>
<p>## Project partners<br>
Bridges to Development<br>
University of South Australia Centre for Change and Complexity in Learning (C3L)</p>
<p>## Roles and responsibilities<br>
- Design: The Geneva Learning Foundation<br>
- Implementation (sample collection): The Geneva Learning Foundation<br>
- Processing: The Geneva Learning Foundation, Bridges for Development, Centre for Complexity and Change in Learning (C3L)<br>
- Anonymization: The Geneva Learning Foundation and Bridges for Development<br>
- Data cleaning: Bridges to Development<br>
- Submission: The Geneva Learning Foundation</p>
<p>## Funding sources or sponsorship that supported the data collection<br>
Wellcome, Bill & Melinda Gates Foundation (BMGF)</p>
<p>## Recommended citation<br>
The Geneva Learning Foundation, 2023. Value Creation Stories (VCS) weekly feedback survey, 2022 Full Learning Cycle (FLC) of the Movement for Immunization Agenda 2030 (IA2030) (Version 1.0). [Data Set]. The Geneva Learning Foundation. DOI: 10.5281/zenodo.7763922</p>
<p># Description of the sample</p>
<p>## File list:</p>
<p>This file is IA2030_FLC_2022_Value_Creation_Stories.README.md</p>
<p>IA2030-EN_FLC_2022_Value_Creation_Stories-questions_mapping.csv : List of the survey’s questions and their code in English as well as their unit. (21 questions) - Version 1: Geneva Learning Foundation, 31 March 2023. </p>
<p>IA2030-EN_FLC_2022_Value_Creation_Stories.csv : Dataset Response of participants that replied in English. (n: 2101, obs:5601) - Version 1: Geneva Learning Foundation, 31 March 2023. </p>
<p>IA2030-FR_FLC_2022_Value_Creation_Stories-questions_mapping.csv: List of the survey’s questions and their code in English as well as their unit. (21 questions) - Version 1: Geneva Learning Foundation, 31 March 2023.</p>
<p>IA2030-FR_FLC_2022_Value_Creation_Stories-Google_translation.csv: Dataset Response of participants that replied in French translated to English using “Google Translate” (n: 1585, obs:4493) - Version 1: Geneva Learning Foundation, 31 March 2023.</p>
<p>IA2030-FR_FLC_2022_Value_Creation_Stories.csv: Dataset Response of participants that replied in French (n: 1585, obs:4493) - Version 1: Geneva Learning Foundation, 31 March 2023. Relationship between files: The questions codes data set are the same code as the column variables and can be connected.</p>
<p>## Relationship between files<br>
The questions codes data set are the same code as the column variables and can be connected.</p>
<p>## Related data sets<br>
This is a subset of data collected by The Geneva Learning Foundation (TGLF) during the 1st IA2030 Full Learning Cycle (FLC). The complete data set is more comprehensive, and includes: demographic information (gender, country), health system information (respondent’s health system level), respondents’ analyses of challenges and priorities. </p>
<p>Additional data sets for the first Full Learning Cycle (FLC) of the Movement for Immunization Agenda 2030 (IA2030) are available from The Geneva Learning Foundation (TGLF) Insights Unit [[email protected]]([email protected])</p>
<p>## Other publicly accessible locations of the data<br>
The Geneva Learning Foundation publishes data sets in relation to its Immunization Agenda 2030 (IA2030) Movement learning programme in the Zenodo open repository community: https://zenodo.org/communities/ia2030/</p>
<p>## 1. Purpose and Objectives</p>
<p>### Primary goal of the survey:<br>
This survey had two goals in the context of TGLF’s IA2030 Movement Full Learning Cycle programme (2022): <br>
1. Provide an asynchronous mechanism for support between peers (participants) and from the TGLF team; and<br>
2. collect and measure programme participants’ value creation stories (VCS) during the programme.</p>
<p>Martin de Laat’s “value creation stories” (VCS) has been used primarily in small-scale, qualitative studies of communities of practice, online forums, and education activities.</p>
<p>This data set includes both quantitative (Likert) and qualitative (open text) responses to the VCS questions, collected over a period of four months (7 March – 20 June 2022) from a cohort that began with 6,185 participants on the start date.</p>
<p>## 2. Population and Sample</p>
<p>The target population were participants of the Geneva Learning Foundation’s Movement for Immunization Agenda 2030 (IA2030) learning programme. The initial cohort admitted to the programme was 6,185 individuals from 99 countries. Only participants who were formally admitted to the programme received the invitation to complete the survey.</p>
<p>Programme participants were free to choose if and when to report (self-selection), and their responses were not checked against any other measures (self-reporting).</p>
<p>### Languages: French and English</p>
<p>## 3. Survey Design and Methods</p>
<p>Data collection period: 7 March 2022 – 20 June 2022</p>
<p>Between 7 March and 20 June 2023, participants in the Geneva Learning Foundation’s “Immunization Agenda 2030” (IA2030) Movement Full Learning Cycle (FLC) were asked to respond to a questionnaire titled “How are you doing?”.</p>
<p>Participants received a personalized email with the request to share feedback about their experience during the week. The link to share feedback was also included in other reminder and information emails sent in response to participant needs.</p>
<p>The first survey was launched on the 11 of March 2022 and the last at 17 of March 2022, totalizing 15 requests. Participants could answer the survey at any time and as many times that they wished.</p>
<p> <br>
The group of 6,185 participants grew over the course of the Cycle, as additional participants were able to join the initiative throughout the four-month period.</p>
<p>### Software- or Instrument-specific information needed to interpret the data<br>
- Automated translation of French data was performed using [Google Translate](https://translate.google.com/?sl=en&tl=fr&op=docs)<br>
- Methods used for removing or anonymizing personal identifiers or sensitive information:<br>
- Unique identifier: Unique identifiers were anonymized using MD5 Hashing via the web site [Miracle Salad](https://www.miraclesalad.com/webtools/md5.php.).Unique identifiers can be used to identify respondents who may have answered the survey more than once, at different points in time. This approach provides a method to anonymize sensitive data using MD5 hashing.*Limitation: MD5 hashing is a one-way function; it is not possible to dehash the data and recover the original information.**<br>
- Macros developed in Excel to replace Country names in qualitative responses. (No country information were collected in this survey, but some respondents referred to their specific contexts in their responses.) The macro did not account for typos, in case any country information is found please contact: [[email protected]]([email protected])</p>
<p>### Data collection start and end dates:<br>
7 March 2023 until 20 June 2023</p>
<p>#### Events or circumstances during data collection that may have influenced results:<br>
No requests for responses were sent during TGLF’s “Term break” between 16-30 April 2022.</p>
<p>## 4. Data Processing and Cleaning</p>
<p>- Incomplete or inconsistent responses: Not cleaned, as respondents were able to opt out of specific sections of survey or skip questions.<br>
- Data transformations or imputations: None<br>
- Treatment of outliers or extreme values: None</p>
<p>## 5. Variables and Measures</p>
<p>The survey included Likert scale questions and qualitative open texts based the conceptual framework for Value Creation Stories (VCS) developed by Wenger et. al. (2011). There are no derived or calculated variables. Items are Likert scale, multiple choice, and open text.</p>
<p>## 6. Data Quality and Reliability<br>
All the responses done before or after the FLC period (7 March – 20 June 2022) were excluded of the sample.</p>
<p>## 7. Data Privacy and Anonymization</p>
<p>### Methods used for removing or anonymizing personal identifiers or sensitive information:<br>
- Unique identifier: Unique identifiers were anonymized using MD5 Hashing via the web site https://www.miraclesalad.com/webtools/md5.php. Unique identifiers can be used to identify respondents who may have answered the survey more than once, at different points in time. This approach provides a method to anonymize sensitive data using MD5 hashing.<br>
- Limitation: MD5 hashing is a one-way function; it is not possible to dehash the data and recover the original information. <br>
- Macros developed in Excel to replace Country names in qualitative responses. (No country information were collected in this survey, but some respondents referred to their specific contexts in their responses.)</p>
<p>## 8. Data Availability and Accessibility<br>
This data set is made available on Zenodo.org in the Zenodo community “Movement for Immunization Agenda 2030 (IA2030)”<br>
https://zenodo.org/communities/ia2030/</p>
<p>Requests for additional information should be addressed to [email protected].</p>
<p>This is a subset of data collected by The Geneva Learning Foundation (TGLF) during the 1st IA2030 Full Learning Cycle (FLC).</p>
<p>The complete data set is more comprehensive, and includes: demographic information (gender, country), health system information (respondent’s health system level), respondents’ analyses of challenges and priorities.</p>
<p>### Other publicly accessible locations of the data<br>
The Geneva Learning Foundation publishes data sets in relation to its Immunization Agenda 2030 (IA2030) Movement learning programme in the Zenodo open repository community: https://zenodo.org/communities/ia2030/</p>
<p>### Related data sets<br>
Additional data sets for the first Full Learning Cycle (FLC) of the Movement for Immunization Agenda 2030 (IA2030) are available from The Geneva Learning Foundation (TGLF) Insights Unit [email protected]</p>
<p>## 10. Ethical Considerations</p>
<p>### Ethical guidelines followed during data collection:<br>
TGLF’s research abides by the principles of the Cantonal Commission for Research Ethics (CCER), the Federal Law on Research on Human Beings (RS 810.30), Swiss Human Research Act (HRA) and the Ordinance on Organisational Aspects of the Human Research Act (HRA Organisation Ordinance, OrgO-HRA)</p>
<p>### Informed consent and participant rights information:<br>
In order to join TGLF’s IA2030 Full Learning Cycle programme, participants had to confirm their agreement to use of their responses “for research, learning, evaluation, communication, and advocacy, in line with the Foundation’s mission”.</p>
<p>Participants were able to opt out of the VCS questions by selecting “No” when asked “Could we ask you five questions about your participation?”. They were informed these questions were asked in order to “share your feedback in the next weekly Assembly”, the weekly synchronous meeting for programme participants. The rationale for sharing such feedback was also explained; “Your contribution will help everyone understand how we are doing as a group, and also help us to better support you.”</p>
<p>Data protection and confidentiality<br>
Consent was requested during the application and submitted of action plan period for sharing data, in line with the Geneva Learning Foundation’s data protection and confidentiality policy.</p>
<p># Copyright and license<br>
The Geneva Learning Foundation © 2022. This data set and all associated files are licensed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0)</p>
<p>© The Geneva Learning Foundation 2023</p>
<p>Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International; https://creativecommons.org/licenses/by-nc-sa/4.0/.</p>
<p>Under the terms of this license, you may copy, redistribute and adapt the data set for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this data set, there should be no suggestion that the Foundation endorses any specific organization, products or services. The use of the Foundation logo is not permitted. If you use the data set, then you must license your work under the same or equivalent Creative Commons license. If you create a translation of this data set, you should add the following disclaimer along with the suggested citation: “This translation was not created by the Geneva Learning Foundation. The Foundation is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition.”</p>
<p>Any mediation relating to disputes arising under the license shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.</p>
<p>General disclaimers. The designations employed and the presentation of the data set do not imply the expression of any opinion whatsoever on the part of the Foundation concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.</p>
<p>The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the Foundation in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.</p>
<p>All reasonable precautions have been taken by the Foundation to verify the information contained in this data set. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the Foundation be liable for damages arising from its use.</p>
<p>This data set contains individual views and does not necessarily represent the decisions or the policies of the Foundation.</p>
<p>Version 1.0 (31 March 2023): reviewed internally; reviewed externally. </p>
<p># References<br>
Wenger, E., Trayner, B., de Laat, M., 2011. Promoting and assessing value creation in communities and networks: a conceptual framework (Rapport No. 18). Oitpen Universiteit, Ruud de Moor Centrum.</p>
<p>Wenger, E., Trayner, B., de Laat, M., 2011. Promoting and assessing value creation in communities and networks: a conceptual framework (Rapport No. 18). Oitpen Universiteit, Ruud de Moor Centrum.</p>
<p>Victoria J. Marsick, Rachel Fichter, Karen E. Watkins, 2022. From Work-based Learning to Learning-based Work: Exploring the Changing Relationship between Learning and Work, in: The SAGE Handbook of Learning and Work. SAGE Publications.</p>
<p>Watkins, K.E., Sandmann, L.R., Dailey, C.A., Li, B., Yang, S.-E., Galen, R.S., Sadki, R., 2022. Accelerating problem-solving capacities of sub-national public health professionals: an evaluation of a digital immunization training intervention. BMC Health Serv Res 22, 736. https://doi.org/10.1186/s12913-022-08138-4</p>
<p>Watkins, K.E., Kim, K., 2019. Measuring the Impact of the WHO Scholar Programme Courses for Immunization (2016-2018) (Evaluation report). University of Georgia at Athens, Athens, United States.</p>
<p>Watkins, K.E., Bhattarai, A., 2019. Analysis of the Impact Accelerator Launch Pad Individual Acceleration Reports in July 2019. University of Georgia at Athens, Athens, United States.</p>
<p># Questionnaire</p>
<p>## Hello {{fname}} {{lname}}. How are you doing in the Movement for Immunization Agenda 2030?</p>
<p>## Do you need help? Do you want to share your experience? We would like to know how you are doing.<br>
- I am doing fine.<br>
- I have a problem and need help.<br>
- I want to share my experience.</p>
<p>## Tell us more about what you want to share. Be specific and detailed so that we can understand. Share your lessons learned, successes, and challenges.</p>
<p>## Did you complete your action for the week? If you did it, how did it turn out? What did you learn in the process? Did anything surprise you? What will you do next? If you did not complete your action, what will you do differently next week? This is a good way to write your thoughts if you did not get to speak in the last session. You can also record an audio message in the IA2030 Movement Dialogue https://t.me/+-PwJxPpyWfQ0ZjRk or share an idea or practice https://accelerator.wazoku.com/ccc/learning in the Ideas Engine.</p>
<p>## What do you need help with?<br>
- I do not know what I am supposed to do<br>
- I need help with my IA2030 challenge<br>
- I want to catch up<br>
- I have poor connectivity<br>
- I have a problem with technology<br>
- Something else</p>
<p>## Tell us more about the problem you are facing.<br>
What have you tried to solve this problem? Where did you get stuck? The more information you provide, the better colleagues will be able to help you.</p>
<p>## Have you tried taking time to read and follow the instructions? </p>
<p>Click here https://www.learning.foundation/products/movement-for-immunization-agenda-2030-full-learning-cycle-1-march-2022 to access the video tutorials and slide decks on www.learning.foundation https://www.learning.foundation/login. </p>
<p>Use your email email to log in. Don’t remember your password?</p>
<p>Click here to recover it https://www.learning.foundation/password/new. </p>
<p>Take the time to read the instructions – and then follow them step-by-step. Do not forget to come back to finish this questionnaire. </p>
<p>## Do not suffer in silence. It sounds like you should ask for help from your Movement colleagues. </p>
<p>Click here to connect with colleagues https://t.me/IA2030 in the IA2030 Movement Telegram channel.<br>
- When you join Telegram, please introduce yourself and explain the problem that you are facing. Your colleagues can only help you if you describe the issue and explain what you have already done to solve it.<br>
- We encourage you to share your challenge in the next short session where we share experience and problem-solve. Click here to register https://us02web.zoom.us/j/86171141804, and then come back to finish this questionnaire.<br>
- Surely, someone will be able to help you. But you do have to register https://us02web.zoom.us/j/86171141804 and actually show up at the right time!<br>
- Poor connectivity? Click here to listen https://podcasts.google.com/feed/aHR0cHM6Ly9saXN0ZW5ib3guYXBwL2YvODRTTFI0eTY5X05h to our low-bandwidth podcast. And then come back to finish this questionnaire.<br>
- You can listen to most sessions in our podcast. This is audio-only, like listening to radio on demand.</p>
<p>## Could we ask you five questions about your participation?<br>
We will share your feedback in the next weekly Assembly. Your contribution will help everyone understand how we are doing as a group, and also help us to better support you.</p>
<p>Yes<br>
No</p>
<p>## Participation changed me as a professional<br>
(change in skills, a
IA2030 Action Plans and Impact Acceleration Reports: Survey responses from 931 national and sub-national staff (Immunization Agenda 2030 Full Learning Cycle 2022)
No full text<p># IA2030 Action Plans and Impact Acceleration Reports: Survey responses from 931 national and sub-national staff (Immunization Agenda 2030 Full Learning Cycle 2022)</p>
<p>Note: This document includes markdown syntax to facilitate machine reading.</p>
<p>## Table of Contents<br>
- Abstract<br>
- Research Audience<br>
- Credits<br>
- Recommended Citation<br>
- File List<br>
- Related Data Sets<br>
- Background<br>
- Data Set Structure and Contents<br>
- Data Cleaning, Data Privacy, and Anonymization<br>
- Ethical Considerations<br>
- Survey Implementation<br>
- Survey Questionnaire Items<br>
- Data Availability and Accessibility<br>
- Copyright and License<br>
- References</p>
<p>## Abstract</p>
<p>The Immunization Agenda 2030 (IA2030) has been endorsed at the World Health Assembly as the world’s strategy for immunization.</p>
<p>The Movement for IA2030 is a voluntary collective of immunization practitioners, principally from low- and middle-income countries, who have pledged to support each other to accelerate local action in support of this global immunization strategy.</p>
<p>This data set offers insights into how to understand national and sub-national challenges facing immunization programmes and what strategies show promise for addressing these challenges over time. It contains:<br>
- raw, anonymized data in Excel CSV format. Copies of the three survey questionnaires are available for download in the Files section (below).<br>
- responses to one, two, or three surveys from 931 national and subnational immunization practitioners participating in the Movement for Immunization Agenda (IA) 2030:</p>
<p>Survey 1: IA2030 Action Plan Survey: a 77-item questionnaire, fielded in May 2022, which asked respondents to identify a key challenge relevant to their immunization programme, root cause of the challenge, three corrective actions, and what they knew about vaccination coverage in their zone of intervention.</p>
<p>Survey 2: IA2030 Impact Acceleration Report Survey (2022): a 27-item questionnaire, fielded in June 2022, which asked respondents to report progress on implementation of their IA2030 Action Plan, including progress on vaccination coverage indicators.</p>
<p>Survey 3: IA2030 Impact Acceleration Report Survey (2023): a 60-item questionnaire, fielded in June 2023, which asked respondents to report progress on implementation of their IA2030 Action Plan, including progress on vaccination coverage indicators.</p>
<p>## Research Audience</p>
<p>Education and global health researchers with interest in human resources for health (HRH) and the characteristics, priority challenges, and experiences of national and sub-national immunization staff participating in the Movement for Immunization Agenda (IA) 2030.</p>
<p>## Credits</p>
<p>### Author</p>
<p>The Geneva Learning Foundation (TGLF)<br>
18 Avenue Louis Casaï <br>
CH1209 Geneva, Switzerland<br>
[email protected]</p>
<p>Principal Investigator and Corresponding Author<br>
Reda Sadki, TGLF<br>
[email protected]</p>
<p>Project Partners<br>
- Biostat Global Consulting (BGC)<br>
- Bridges to Development<br>
- Centre for Change & Complexity in Learning (C3L)</p>
<p>Partner Roles and Responsibilities<br>
- Design: TGLF<br>
- Implementation (sample collection): TGLF<br>
- Processing: TGLF, C3L<br>
- Anonymization: BGC<br>
- Submission: TGLF<br>
- Maintenance of learning analytics database where data are stored: C3L</p>
<p>Funding<br>
Wellcome Trust, Bill & Melinda Gates Foundation (BMGF)</p>
<p>## Recommended Citation</p>
<p>Action Plans and Impact Acceleration Reports: Responses from 931 national and sub-national staff (Immunization Agenda 2030 Full Learning Cycle). The Geneva Learning Foundation, 2023. (Version 1.0) [Data Set]. The Geneval Learning Foundation. https://doi.org/10.5281/zenodo.8298773</p>
<p>## File List</p>
<p>2023-09.IA2030_Action_Plans_and_Impact_Acceleration_Reports.README.md (this document)</p>
<p>2022-05.IA2030_Action_Plan_Survey.docx: List of items included in the Action Plan Survey</p>
<p>2022-06.IA2030_Impact_Acceleration_Report_Survey.docx: List of items included in the Impact Acceleration Report Survey questionnaire administered in June 2022.</p>
<p>2023-06.IA2030_Impact_Acceleration_Report_Survey.docx: List of additional items included in the Impact Acceleration Survey administered in June 2023 (the complete survey questionnaire also included all items included in the June 2022 Impact Acceleration Report Survey questionnaire).</p>
<p>2023-09.IA2030_Action_Plans_and_Impact_Acceleration_Reports_Survey_Dataset.csv: Anonymized Action Plans and Acceleration Reports Survey Dataset. Version 1: Geneva Learning Foundation (937 observations, 173 variables).</p>
<p>## Related Data Sets</p>
<p>The 2023-09.IA2030_Action_Plans_and_Impact Acceleration_Reports_Survey_Dataset.csv is a subset of data collected by The Geneva Learning Foundation (TGLF) during the first IA2030 Full Learning Cycle (FLC) during May 2022, June 2022, and June 2023. The complete IA 2030 Action Plans and Impact Acceleration Reports Survey data set is more comprehensive and includes information about respondent and programme characteristics as well as responses to open-text questions. </p>
<p>Researchers who would like to analyze the full set of unredacted responses are invited to contact the Geneva Learning Foundation to inquire about a data sharing agreement that would stipulate conditions of access ([email protected]).</p>
<p>The Geneva Learning Foundation, 2023. Value Creation Stories (VCS) weekly feedback survey, 2022 Full Learning Cycle (FLC) of the Movement for Immunization Agenda 2030 (IA2030) (Version 1.0). [Data Set]. The Geneva Learning Foundation. https://doi.org/10.5281/zenodo.7763922 </p>
<p>The Geneva Learning Foundation, 2023. Full Learning Cycle (2022) Application for national and sub-national immunization staff to identify challenges and join the Movement for Immunization Agenda (IA 2030) (Version 1.0) [Data Set]. The Geneval Learning Foundation. https://doi.org/10.5281/zenodo.8199552</p>
<p>Additional data sets for the first Full Learning Cycle (FLC) of the Movement for Immunization Agenda 2030 (IA2030) are available from TGLF’s Insights Unit ([email protected]).</p>
<p>## Background</p>
<p>The Immunization Agenda 2030 (IA2030), the global immunization strategy for 2021-2030, set ambitious targets for global immunization coverage and other key indicators (World Health Organization [WHO], 2020).</p>
<p>In response to the WHO Director-General’s call for a social movement to ensure immunization remains a priority for global and regional health agendas and promote broad societal support for immunization (WHO, 2020), TGLF, working with its global community of over 35,000 alumni, developed a learning programme intended to contribute to a “Movement for Immunization Agenda 2030.” As part of their participation in the programme, IA2030 participants developed a locally tailored action plan designed to address a key challenge relevant to their immunization programme. A project kick-off phase, the “Impact Accelerator Launch Pad”, supported participants during their initial implementation stages, to create momentum for sustained action. One month after initiation of their Action Plan(s), participants were invited to complete an Impact Acceleration survey questionnaire to assess progress towards their goals. One year later, programme participants were invited to complete a second Impact Acceleration questionnaire to assess continued progress towards their goal.</p>
<p>This data set includes participants’ responses to one or more questionnaires documenting their IA2030 experience:<br>
- Survey 1: IA2030 Action Plan Survey: a 77-item questionnaire, fielded in May 2022, which asked respondents to identify a key challenge relevant to their immunization programme, root cause of the challenge, three corrective actions, and what they knew about vaccination coverage in their zone of intervention.<br>
- Survey 2: IA2030 Impact Acceleration Report Survey (2022): a 27-item questionnaire, fielded in June 2022, which asked respondents to report progress on implementation of their IA2030 Action Plan, including progress on vaccination coverage indicators.<br>
- Survey 3: IA2030 Impact Acceleration Report Survey (2023): a 60-item questionnaire, fielded in June 2023, which asked respondents to report progress on implementation of their IA2030 Action Plan, including progress on vaccination coverage indicators.</p>
<p>## Data Set Structure and Contents</p>
<p>The data set has 937 observations and 173 variables. Contents include the following:<br>
- 937 responses (532 English; 405 French) to the Action Plan Survey. Six individuals submitted two distinct Action Plans.<br>
- 538 responses (278 English; 260 French) to the 2022 Impact Acceleration Report Survey<br>
- 236 responses (126 English; 110 French) to the 2023 Impact Acceleration Report Survey<br>
- Column A describes the type of data included in each row of the data file<br>
- The first two rows of the data set hold the question text in English and in French<br>
- Column B contains a unique identifier for each respondent. The ID is a simple string starting with a number to indicate a unique person and then a dash, and then a 1 or a 2 to indicate whether it is their first or second entry for the 2022 Impact Acceleration Report Survey. <br>
- Columns D-F indicate the language each respondent used for each of the three questionnaires (EN = English; FR = French)<br>
- The columns whose names start with I1 were collected as part of the Action Plan Survey, I2 as part of the 2022 Impact Acceleration Report Survey, and I3 as part of the 2023 Impact Acceleration Report Survey. The columns appear in left-to-right order in which the original surveys were administered.</p>
<p>## Data Cleaning, Data Privacy, and Anonymization</p>
<p>Duplicate surveys submitted by the same individual were removed from the data set. When a respondent submitted multiple versions of the Action Plan or 2023 Impact Acceleration Report Survey, the submission with the most complete responses was retained. Six persons submitted two distinct records for the 2022 Impact Acceleration Report Survey. In those cases, both responses appear in the dataset, paired with that person’s single retained entry for the Action Plan and their single retained entry for the 2023 Impact Acceleration Report Survey (where applicable).</p>
<p>The data file shared on this site is intentionally incomplete. Columns containing holding personally identifying information (e.g., respondent email address, date of birth, WhatsApp number, organization name, country) and columns potentially holding personally identifying information (e.g., responses to items such as “summarize your challenge,” “tell us about your stakeholders”) have been replaced with the following phrases:</p>
<p>- “Removed to protect personally identifying information” (English questionnaires)<br>
- “Supprimé pour protéger les informations personnelles” (French questionnaires)</p>
<p>## Ethical Considerations </p>
<p>Ethical clearance for each of the three surveys was granted by TGLF prior to its administration. Privacy was safeguarded by data management complying with the [General Data Protection Regulation](https://gdpr-info.eu/). All participants were informed that participation was voluntary and were assured their data would be confidential. Participants provided consent prior to completing each survey. Respondents did not receive any incentive for participating in any of the surveys.</p>
<p>All information collected for the three surveys was secured with multiple levels of encryption and access controls to guarantee participant confidentiality, per [Typeform policy](https://www.typeform.com/help/a/security-at-typeform-360029259552/)).</p>
<p>## Survey Implementation</p>
<p>For each of the three surveys, IA2030 participants received an email message inviting them to complete a questionnaire. Respondents accessed the questionnaire by clicking a link contained in the email.</p>
<p>All surveys were hosted on the Typeform server and followed the same methods for protecting respondent privacy (details provided in Ethical Considerations section, above). Respondents were given the choice of completing each questionnaire in either English or French.</p>
<p>All survey questionnaires included a mixture of multiple-choice and open-text items. Overviews of the contents of each survey are provided in the next three subsections. Copies of the survey instruments are available for download in the Files section (below).</p>
<p>## Survey Questionnaire Items</p>
<p>### IA 2030 Action Plan Survey Items</p>
<p>- To start your IA2030 Action Plan, describe one challenge you face in your immunization work. We suggest you focus on your most difficult and important challenge. Focus on only one problem where you can take action. Be specific about your situation, not generalities. Help others understand why it matters. Explain your situation. What is the root cause of your challenge? What will be different if you overcome this challenge?<br>
- Summarize your challenge and what you want to do about it.<br>
- Is your challenge too broad, general, or vague, like “coverage is too low” or “there are unvaccinated children”? Can you take action at your level to tackle this challenge?<br>
- Immunization Agenda 2030 is organized into seven Strategic Priorities (SP). Review the list carefully to select the Strategic Priority that best fits your challenge. IA2030 Strategic Priorities are organized into 47 Key Focus Areas (KFAs). Review the list carefully to select the item that best fits your challenge.<br>
- Is your challenge related to any of these?<br>
- To tackle your challenge, define the goal of your IA2030 Action Plan.<br>
- Why is this goal important? Answer the question, “If I achieve my goal, what will be different?” What does success look like?<br>
- Have you started to take action toward this goal?<br>
- Summarize what you have already done toward this goal. Who did what, when and how? How did it turn out? Do you have any concrete results to date? What are the lessons or surprises so far?<br>
- Tell us about your stakeholders. Who will you need to work with to achieve your goal? What type of support will you need from the communities you serve? How should your organization, supervisor, and partners support you? What are the likely barriers to securing their support and commitment? What are you going to do if a stakeholder does not provide the support you need? Could the support of IA2030 Movement colleagues be helpful to you and, if so, how?<br>
- Do you need additional funding to achieve your goal?<br>
- How much time do you need to achieve your goal? (Less than one month, 1-3 months. 4-6 months, 7-12 months, 13-18 months, 19-24 month, more than 24 months)<br>
- Tell us more about resources and timeline. Provide a rough initial estimate of the time and budget required for your Action Plan. If this is premature, indicate what you need to know to be able to determine time and budget required.<br>
- What resources (time, people, money) will you need to achieve your goal? How are you going to secure these resources? Summarize the steps to secure resources.<br>
- Now, we would like you to identify three different, specific actions to achieve the goal of your IA2030 Action Plan: Action 1. What do you want to do? Have you done this before? Who will carry out this action? How much time do you need to finish this action? How innovative is this action? Tell us more about this action?<br>
- Explain why this action matters. How will this action help you achieve your goal? What needs to happen and when? What are the steps to finish this action? Who will carry out this action? How will you know when you have finished your action? How will you know if your action is successful?<br>
- What else needs to happen to achieve your goal?<br>
- What other actions need to be taken? When do they need to happen? Who will carry them out? How will these actions help to achieve your goal? What is your role in them? What control do you have over these actions?<br>
- Do you wish to share experience to help you with your IA2030 Action Plan and to help others?<br>
- What is the name of your organizational unit or area of intervention?<br>
- What is the main type of environment in: [your zone of intervention]?<br>
- Do you know the size of the vaccination target population in: [your zone of intervention]?<br>
- What is the size of the population in: [your zone of intervention]?<br>
- Do you know the number of outreach immunization sessions that were planned and then actually carried out last year:<br>
- What was the number of planned outreach immunization sessions held last year in: [your zone of intervention]?<br>
- What was the number of outreach immunization sessions that were actually carried out last year in: [your zone of intervention]?<br>
- Do you know the Antenatal Care (ANC) Coverage in: [your zone of intervention]?<br>
- What is the Antenatal Care (ANC) Coverage in: [your zone of intervention]?<br>
- Do you know the current Penta 1 coverage in: [your zone of intervention]?<br>
- What is the current Penta 1 coverage in: [your zone of intervention]?<br>
- Do you know the current Penta 3 coverage in: [your zone of intervention]?<br>
- What is the current Penta 3 coverage in: [your zone of intervention]?<br>
- Do you know the MCV1 immunization coverage in: [your zone of intervention]?<br>
- What is the MCV1 immunization coverage in: [your zone of intervention]?<br>
- Do you know the MCV2 immunization coverage in: [your zone of intervention]?<br>
- What is the MCV2 immunization coverage in: [your zone of intervention]?<br>
- Do you know the vaccination coverage for the first dose of COVID-19 vaccine in: [your zone of intervention]?<br>
- What is the vaccination coverage for the first dose of COVID-19 vaccine in your area?<br>
- You have now prepared your IA2030 Action Plan. Are you ready to take action? If your Action Plan is accepted, you will be invited to join the 2nd IA2030 Impact Accelerator Launch Pad to work with others during four weeks to start implementing your Action Plan.<br>
- What will you seek to achieve in the FOUR WEEKS of the Launch Pad?<br>
- What is the MOST IMPORTANT ACTION that you will carry out in the first 7 days of joining the Launch Pad?</p>
<p>### IA2030 Impact Acceleration Report Survey Items (2022)</p>
<p>- Has there been a CHANGE or PROGRESS since your last Acceleration Report? Tell us what has happened. -What has changed since your last Acceleration Report?<br>
- What is the implementation status of your action plan?<br>
- (If applicable) Please tell us why you have not yet started to implement your IA2030 action plan. What are the barriers or obstacles that have prevented you from starting implementation? What support do you need that will help you overcome these barriers? What will you do now to start implementing?<br>
- Tell us more about the implementation status of your action plan. What actions did you take and what changed as a result of your actions? What are the results? What were the challenges and how did you address them? What strategies or solutions were critical to implementation? Who or what helped you? What lessons did you learn? Was there anything that surprised you? Is there anything else you would like us to know?<br>
- Is your action plan integrated with the broader EPI programme?<br>
- Has participation in your Scholar Country Team’s activities been USEFUL to you?<br>
- Have you interacted personally with other members of the IA2030 Movement since your last Acceleration Report?? (If yes) What was the main reason for this interaction?<br>
- How many Movement members have you personally interacted with since your last Acceleration Report?<br>
- Name up to three Movement members that you have personally interacted with since your last Acceleration Report.<br>
- Do you have something you would like to share about implementation of your IA2030 action plan? (If yes) Please tell us what happened and how it turned out. Why does this matter? How did you identify it? What have you done to learn more about it? What strategies or solutions have you tried or would you consider? Who or
Going Beyond Counting First Authors in Author Co-citation Analysis
Get PDFThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
Get PDF“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Appropriate Similarity Measures for Author Cocitation Analysis
Get PDFWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Dispelling the Myths Behind First-author Citation Counts
Get PDFWe conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
- …
